Your browser doesn't support javascript.
loading
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
Wang, Yingcong; Dong, Sanfeng; Hu, Ke; Xu, Li; Feng, Qilin; Li, Bo; Wang, Guangli; Chen, Gege; Zhang, Bibo; Jia, Xinyan; Xu, Zhijian; Gao, Xuejie; Zhang, Hui; Xie, Yongsheng; Lu, Meiling; Chang, Shuaikang; Song, Dongliang; Wu, Xiaosong; Jia, Qi; Zhu, Huabin; Zhou, Jinfeng; Zhu, Weiliang; Shi, Jumei.
Afiliación
  • Wang Y; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Dong S; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Hu K; CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Xu L; Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Feng Q; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Li B; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Wang G; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Chen G; CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhang B; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Jia X; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Xu Z; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, 315000, China.
  • Gao X; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Zhang H; CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Xie Y; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Lu M; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Chang S; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Song D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Wu X; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Jia Q; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Zhu H; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Zhou J; Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Zhu W; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Shi J; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
J Transl Med ; 21(1): 858, 2023 11 27.
Article en En | MEDLINE | ID: mdl-38012658

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Animals / Humans Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Animals / Humans Idioma: En Revista: J Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China